Stock TNDM TANDEM DIABETES CARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tandem Diabetes Care, Inc.

Equities

TNDM

US8753722037

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
47.23 USD -0.15% Intraday chart for Tandem Diabetes Care, Inc. +7.51% +59.67%
May. 15 Transcript : Tandem Diabetes Care, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM
May. 03 Sector Update: Health Care Stocks Mixed in Afternoon Trading MT

Business Summary

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Number of employees: 2,400

Sales per Business

USD in Million2022Weight2023Weight Delta
Supplies and Other
54.4 %
- - 407 54.4 % -
Pump
50.1 %
432 53.9 % 374 50.1 % -13.34%
Deferral for Tandem Choice Program
-3.4 %
-4 -0.4 % -25 -3.4 % +607.44%
Pump Rebate
-1.1 %
- - -8 -1.1 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
74.2 %
589 73.5 % 555 74.2 % -5.76%
Non-United States
25.8 %
212 26.5 % 193 25.8 % -9.23%

Managers

Managers TitleAgeSince
John Sheridan CEO
 Chief Executive Officer 68 13-02-28
Leigh Vosseller DFI
 Director of Finance/CFO 51 13-08-31
Shannon Hansen CMP
 Compliance Officer 58 21-12-31
Jordan Pinsker CTO
 Chief Tech/Sci/R&D Officer - 21-04-25
Peter Rossiter CTO
 Chief Tech/Sci/R&D Officer - 20-04-30
Michael Michaud CTO
 Chief Tech/Sci/R&D Officer - 19-08-31
Susan Morrison ADM
 Chief Administrative Officer 44 07-10-31
Rick Carpenter CTO
 Chief Tech/Sci/R&D Officer 60 21-12-01
Kim Blickenstaff BRD
 Director/Board Member 71 07-08-31
Mark Novara PRN
 Corporate Officer/Principal - Nov. 12

Members of the board

Members of the board TitleAgeSince
Rebecca Robertson CHM
 Chairman 63 19-01-02
Christopher Twomey BRD
 Director/Board Member 64 13-06-30
Kim Blickenstaff BRD
 Director/Board Member 71 07-08-31
John Sheridan CEO
 Chief Executive Officer 68 13-02-28
Kathleen McGroddy-Goetz BRD
 Director/Board Member 60 20-06-07
Dick Allen BRD
 Director/Board Member 79 07-06-30
Peyton Howell BRD
 Director/Board Member 57 20-08-02
Rajwant Singh Sodhi BRD
 Director/Board Member 50 20-12-31
Myoung Cha BRD
 Director/Board Member 47 22-06-14
Joao Malagueira BRD
 Director/Board Member 58 22-06-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 64,589,518 64,166,671 ( 99.35 %) 0 99.35 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
13.43 %
8,672,402 13.43 % 308 M $
Vanguard Fiduciary Trust Co.
10.92 %
7,052,570 10.92 % 251 M $
Capital Research & Management Co. (World Investors)
5.677 %
3,665,300 5.677 % 130 M $
Marshall Wace LLP
4.833 %
3,120,374 4.833 % 111 M $
ArrowMark Colorado Holdings LLC
4.545 %
2,934,179 4.545 % 104 M $
Jennison Associates LLC
3.959 %
2,556,124 3.959 % 91 M $
STATE STREET CORPORATION
3.471 %
2,240,978 3.471 % 80 M $
Janus Henderson Investors US LLC
3.409 %
2,200,797 3.409 % 78 M $
Bellevue Asset Management AG
3.147 %
2,031,888 3.147 % 72 M $
BNY Mellon Investment Adviser, Inc.
2.675 %
1,726,825 2.675 % 61 M $

Company contact information

Tandem Diabetes Care, Inc.

12400 High Bluff Drive

92130, San Diego

+858 366 6900

http://www.tandemdiabetes.com
address Tandem Diabetes Care, Inc.(TNDM)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Sales per Business

Sales per region

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
47.23 USD
Average target price
44.43 USD
Spread / Average Target
-5.93%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
TANDEM DIABETES CARE, INC. Stock Tandem Diabetes Care, Inc.
+59.67% 3.06B
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.23% 181B
MEDTRONIC PLC Stock Medtronic plc
+2.59% 114B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.75% 68.29B
DEXCOM, INC. Stock DexCom, Inc.
+5.32% 52.24B
CENCORA, INC. Stock Cencora, Inc.
+7.61% 44.3B
HOYA CORPORATION Stock Hoya Corporation
+5.28% 42.73B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+25.17% 32.52B
TERUMO CORPORATION Stock Terumo Corporation
+17.61% 26.02B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-2.66% 25.91B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. TNDM Stock
  4. Company Tandem Diabetes Care, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW